| Chronic kidney disease P Romagnani, G Remuzzi, R Glassock, A Levin, KJ Jager, M Tonelli, ... Nature reviews Disease primers 3 (1), 1-24, 2017 | 1048 | 2017 |
| Cardiovascular and noncardiovascular mortality among patients starting dialysis DJ De Jager, DC Grootendorst, KJ Jager, PC Van Dijk, LMJ Tomas, ... Jama 302 (16), 1782-1789, 2009 | 901 | 2009 |
| A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases KJ Jager, C Kovesdy, R Langham, M Rosenberg, V Jha, C Zoccali Nephrology Dialysis Transplantation 34 (11), 1803-1805, 2019 | 837 | 2019 |
| Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease JJ Carrero, M Hecking, NC Chesnaye, KJ Jager Nature Reviews Nephrology 14 (3), 151-164, 2018 | 707 | 2018 |
| CKD prevalence varies across the European general population K Brück, VS Stel, G Gambaro, S Hallan, H Völzke, J Ärnlöv, M Kastarinen, ... Journal of the American Society of Nephrology 27 (7), 2135-2147, 2016 | 682 | 2016 |
| When do we need competing risks methods for survival analysis in nephrology? M Noordzij, K Leffondré, KJ van Stralen, C Zoccali, FW Dekker, KJ Jager Nephrology Dialysis Transplantation 28 (11), 2670-2677, 2013 | 681 | 2013 |
| Sample size calculations: basic principles and common pitfalls M Noordzij, G Tripepi, FW Dekker, C Zoccali, MW Tanck, KJ Jager Nephrology dialysis transplantation 25 (5), 1388-1393, 2010 | 575 | 2010 |
| Changes in the worldwide epidemiology of peritoneal dialysis PKT Li, KM Chow, MWM Van de Luijtgaarden, DW Johnson, KJ Jager, ... Nature Reviews Nephrology 13 (2), 90-103, 2017 | 553 | 2017 |
| Quality of life in patients on chronic dialysis: self-assessment 3 months after the start of treatment MP Merkus, KJ Jager, FW Dekker, EW Boeschoten, P Stevens, RT Krediet, ... American journal of kidney diseases 29 (4), 584-592, 1997 | 541 | 1997 |
| Confounding: what it is and how to deal with it KJ Jager, C Zoccali, A Macleod, FW Dekker Kidney international 73 (3), 256-260, 2008 | 536 | 2008 |
| Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe KJ Jager, A Kramer, NC Chesnaye, C Couchoud, JE Sánchez-Álvarez, ... Kidney international 98 (6), 1540-1548, 2020 | 532 | 2020 |
| Selection bias and information bias in clinical research G Tripepi, KJ Jager, FW Dekker, C Zoccali Nephron Clinical Practice 115 (2), c94-c99, 2010 | 492 | 2010 |
| Cohort studies: prospective versus retrospective AM Euser, C Zoccali, KJ Jager, FW Dekker Nephron Clinical Practice 113 (3), c214-c217, 2009 | 478 | 2009 |
| Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices BM Robinson, T Akizawa, KJ Jager, PG Kerr, R Saran, RL Pisoni The Lancet 388 (10041), 294-306, 2016 | 453 | 2016 |
| The european renal association–european dialysis and transplant association (ERA-EDTA) registry annual report 2015: a summary A Kramer, M Pippias, M Noordzij, VS Stel, N Afentakis, PM Ambühl, ... Clinical kidney journal 11 (1), 108-122, 2018 | 451 | 2018 |
| External validation of prognostic models: what, why, how, when and where? CL Ramspek, KJ Jager, FW Dekker, C Zoccali, M van Diepen Clinical Kidney Journal 14 (1), 49-58, 2021 | 433 | 2021 |
| COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration LB Hilbrands, R Duivenvoorden, P Vart, CFM Franssen, MH Hemmelder, ... Nephrology Dialysis Transplantation 35 (11), 1973-1983, 2020 | 431 | 2020 |
| Renal replacement therapy in Europe: the results of a collaborative effort by the ERA–EDTA registry and six national or regional registries PCW van Dijk, KJ Jager, F de Charro, F Collart, R Cornet, FW Dekker, ... Nephrology Dialysis Transplantation 16 (6), 1120-1129, 2001 | 412 | 2001 |
| The systemic nature of CKD C Zoccali, R Vanholder, ZA Massy, A Ortiz, P Sarafidis, FW Dekker, ... Nature Reviews Nephrology 13 (6), 344-358, 2017 | 405 | 2017 |
| Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis K Kiryluk, Y Li, S Sanna-Cherchi, M Rohanizadegan, H Suzuki, F Eitner, ... PLoS genetics 8 (6), e1002765, 2012 | 400 | 2012 |
